Webinar
Enhancing Obesity Trials with Integrated eCOA and Digital Endpoint Technologies
calendar

June 26, 2025

Calendar
clock

11:00am - 12:00pm

(GMT-04:00)

Register

View all IQVIA events

In the evolving landscape of clinical trials, the integration of electronic clinical outcome assessments (eCOA) and digital endpoints such as weight and body composition, actigraphy, and sleepscales are revolutionizing the approach to obesity research.

In this webinar, IQVIA experts Anthony Mikulaschek and Michael Bruhns will explore how these technologies can synergistically work together to provide more comprehensive and accurate data, ultimately leading to better outcomes in obesity trials. Join us for an insightful session where these industry experts will share their experience harnessing the power of eCOA and digital endpoint collecting devices to advance obesity trials.

Featured Speakers

Anthony Mikulaschek

Vice President, Patient Commercial Strategy IQVIA
As vice president of DPS Patient Commercial Strategy at IQVIA, Anthony Mikulaschek manages all commercial aspects of the IQVIA Patient Suite of applications including eCOA, IRT, and eConsent. Previously, he was the VP of eCOA Operations for 6 years. Mikulaschek has extensive experience in validated system implementation, systems integration, business process reengineering, IT operations, and consulting. He has successfully led the development, delivery, and management of technology solutions for over 37 years, including 30 years in the pharmaceutical sector.

Michael Bruhns

Senior Director and Commercial Lead, Device Strategy IQVIA Connected Devices
Michael Bruhns is the senior director at IQVIA for connected devices. He oversees commercial operations, strategic device partnerships, and global logistics. Bruhns’s 20+ years of experience span various industries. He is passionate about developing optimized digital endpoint strategies and creating win-win partnerships to build the broadest, most innovative portfolio of medical-grade devices for use in global clinical research across all service lines, modalities, and therapeutic areas.

Related solutions

Contact Us